학술논문
Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas
Document Type
Abstract
Author
Source
In Blood 6 December 2014 124(21):5435-5435
Subject
Language
ISSN
0006-4971